ETF VEFV VANECK PHARMACEUTICAL ETF - USD
Add to a list
To use this feature you must be a member
Log inSign up

News VanEck Pharmaceutical ETF - USD

ETF

VEFV

US92189F6925

Real-time BOERSE MUENCHEN
Other stock markets
 19:47:00 14/06/2024 BST 		5-day change 1st Jan Change
85.59 EUR +0.06% Intraday chart for VanEck Pharmaceutical ETF - USD +1.22% +16.89%
2020 VanEck Vectors ETF Trust - VanEck Vectors Pharmaceutical ETF Announces Quarterly Dividend, Payable on October 7, 2020 CI
2020 VanEck Vectors Pharmaceutical ETF Announces Quarterly Distribution, Payable on July 8, 2020 CI

All the latest ETF news

US bond ETF issuers anticipate big flows in higher-for-longer rate environment RE
China approves first ETFs tracking Saudi equities, fund managers say RE
US equity funds saw largest weekly outflow in 18 months ahead of Fed decision RE
Roaring Kitty's predictions for GameStop are mostly unfulfilled RE
U.S. stock concentration - it's not all doom and gloom: McGeever RE
Ping an of China Trust - Ping an of China CSI HK Dividend ETF Announces Interim Dividend for Financial Year End December 31, 2024, Payable on July 10, 2024 CI
CSOP Investments VCC - ICBC CSOP FTS Chinese Government Bond Index ETF Announces Dividend Distribution, Payable on 27 June 2024 CI
Hang Seng Investment Index Funds Series Iii - Hang Seng Ftse China 50 Index Etf Announces Interim Dividend for Year Ending 31 December 2024 CI
Hang Seng China Enterprises Index ETF Announces Interim Dividend for the Financial Year Ending 31 December 2024, Payable on 30 July 2024 CI
Japan-focused equity mutual funds cash out as rally loses steam RE
Exclusive-Capital Group shakes up strategy to hit $4 trillion by 2031 RE
CAPITAL GROUP TO EXPAND OVERSEAS, IN FIXED INCOME AND… RE
Capital Group shakes up strategy to hit $4 trillion by 2031 RE
CAPITAL CEO SAYS CENTRAL BANK RATE CUTS TO HELP UNLOCK $2-3 TRIL… RE
CAPITAL CEO SAYS WORLD'S LARGEST ACTIVE FUND MANAGER AIMS FOR $4… RE
More news

ETF Ratings

Description

US92189F6925
Total Expense Ratio 0.35%
Asset Class
Sector
Size
Currency
Provider
Underlying MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
19/12/2011
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 30/05/2024 )

AuM (EUR) 524 M€
AuM 1M 479 M€
AuM 3 months 475 M€
AuM 6 months 365 M€
AuM 12 months 358 M€
  1. Stock Market
  2. ETF
  3. VEFV ETF
  4. News VanEck Pharmaceutical ETF - USD
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW